DNA microarray-based typing of Streptococcus agalactiae isolates

Journal of Clinical Microbiology

Volumn 52, Issue 11, 2014, Pages 3933-3943

  Nitschke, Heike ^a,b   Slickers, Peter ^c   Müller, Elke ^c   Ehricht, Ralf ^c   Monecke, Stefan ^a,c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Elblandklinikum Meißen ^*  (Germany)

^c Alere Technologies GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; MACROLIDE; BACTERIAL DNA; GENETIC MARKER;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA MICROARRAY; ERM A GENE; ERM B GENE; ERM C GENE; GENE CLUSTER; GENE FREQUENCY; GENOMIC ISLAND; GENOTYPE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION STRUCTURE; SEQUENCE ALIGNMENT; STREPTOCOCCUS AGALACTIAE; ANIMAL; CLASSIFICATION; GENETIC MARKER; GENETIC VARIABILITY; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEWBORN; PROCEDURES; STREPTOCOCCUS INFECTION; VETERINARY;

ANIMALS; DNA, BACTERIAL; GENETIC MARKERS; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT, NEWBORN; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84908333802     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02411-14     Document Type: Article

References (55)

1. Kowalska B, Niemiec KT, Drejewicz H, Polak K, Kubik P, Elmidaoui A, Gierowska-Bogusz B, Jaczynska R. 2003. Prevalence of group B streptococcal colonization in pregnant women and their newborns based on the results of examination of patients in the Obstetric and Gynecology Department of the National Research Institute of Mother and Child-a pilot study. Ginekol. Pol. 74:1223-1227. (In Polish.)
2. Kunze M, Ziegler A, Fluegge K, Hentschel R, Proempeler H, Berner R. 2011. Colonization, serotypes and transmission rates of group B streptococci in pregnant women and their infants born at a single University Center in Germany. J. Perinat. Med. 39:417-422. http://dx.doi.org/10.1515/JPM.2011.037.
3. Marconi C, Rocchetti TT, Rall VL, Carvalho LR, Borges VT, Silva MG. 2010. Detection of Streptococcus agalactiae colonization in pregnant women by using combined swab cultures: cross-sectional prevalence study. Sao Paulo Med. J. 128:60-62. http://dx.doi.org/10.1590/S1516-31802010000200003.
4. Müller-Vranjes A, Puntarić D, Curzik D, Sijanović S, Topolovec Z, Kasac Z, Miskulin M. 2011. Prevalence and significance of vaginal group B streptococcus colonization in pregnant women from Osijek, Croatia. Coll. Antropol. 35:21-26.
5. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20. http://dx.doi.org/10.1056/NEJM200001063420103.
6. Baker CJ, Edwards MS. 1995. Group B streptococcal infections, 3rd ed. WB Saunders, Philadelphia, PA.
7. Glantz JC, Kedley KE. 1998. Concepts and controversies in the management of group B streptococcus during pregnancy. Birth 25:45-53. http://dx.doi.org/10.1046/j.1523-536x.1998.00045.x.
8. Puopolo KM, Madoff LC, Eichenwald EC. 2005. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115: 1240-1246. http://dx.doi.org/10.1542/peds.2004-2275.
9. Betriu C, Gomez M, Sanchez A, Cruceyra A, Romero J, Picazo JJ. 1994. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob. Agents Chemother. 38:2183-2186. http://dx.doi.org/10.1128/AAC.38.9.2183.
10. Aracil B, Miñambres M, Oteo J, De La Rosa M, Gómez-Garcés JL, Alos AJ. 2002. Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin. Microbiol. Infect. 8:745-748. http://dx.doi.org/10.1046/j.1469-0691.2002.00450.x.
11. Betriu C, Culebras E, Gómez M, Rodríguez-Avial I, Sánchez BA, Ágreda MC, Picazo JJ. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae . Antimicrob. Agents Chemother. 47:1112-1114. http://dx.doi.org/10.1128/AAC.47.3.1112-1114.2003.
12. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508. http://dx.doi.org/10.1128/AAC.45.12.3504-3508.2001.
13. Schuchat A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
14. Uh Y, Jang IH, Hwang GY, Yoon KJ, Song W. 2001. Emerging erythromycin resistance among group B streptococci in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 20:52-54. http://dx.doi.org/10.1007/s100960000414.
15. Pereira Ude P, Rodrigues Dos Santos A, Hassan SS, Aburjaile FF, Soares Sde C, Ramos RT, Carneiro AR, Guimarães LC, Silva de Almeida S, Diniz CA, Barbosa MS, Gomes de Sá P, Ali A, Bakhtiar SM, Dorella FA, Zerlotini A, Araújo FM, Leite LR, Oliveira G, Miyoshi A, Silva A, Azevedo V, Figueiredo HC. 2013. Complete genome sequence of Streptococcus agalactiae strain SA20-06, a fish pathogen associated to meningoencephalitis outbreaks. Stand. Genomic Sci. 8:188-197. http://dx.doi.org/10.4056/sigs.3687314
16. Kogan G, Uhrín D, Brisson JR, Paoletti LC, Blodgett AE, Kasper DL, Jennings HJ. 1996. Structural and immunochemical characterization of the type VIII group B streptococcus capsular polysaccharide. J. Biol. Chem. 271:8786-8790. http://dx.doi.org/10.1074/jbc.271.15.8786.
17. Kong F, Lambertsen LM, Slotved HC, Ko D, Wang H, Gilbert GL. 2008. Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci. J. Clin. Microbiol. 46:2745-2750. http://dx.doi.org/10.1128/JCM.00189-08.
18. Paoletti LJ, Bradford J, Paoletti LC. 1999. A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts. J. Clin. Microbiol. 37:3759-3760.
19. von Hunolstein C, Parisi L, Tissi L, Recchia S, Alfarone G, Nicolini L, Volpe C, Wagner B, Motlovà J, Orefici G. 1999. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide. J. Med. Microbiol. 48: 983-990. http://dx.doi.org/10.1099/00222615-48-11-983.
20. Wessels MR. 1997. Biology of streptococcal capsular polysaccharides. Soc. Appl. Bacteriol. Symp. Ser. 26:20S-31S.
21. Blumberg HM, Stephens DS, Licitra C, Pigott N, Facklam R, Swaminathan B, Wachsmuth IK. 1992. Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping). J. Infect. Dis. 166:574-579. http://dx.doi.org/10.1093/infdis/166.3.574.
22. Huet H, Martin C, Geslin P, Grimont F, Quentin R. 1993. Ribotyping of Streptococcus agalactiae strains isolated from vaginas of asymptomatic women. Res. Microbiol. 144:457-465. http://dx.doi.org/10.1016/0923-2508 (93)90053-5.
23. Benson JA, Ferrieri P. 2001. Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J. Clin. Microbiol. 39:3006-3008. http://dx.doi.org/10.1128/JCM.39.8.3006-3008.2001.
24. Quentin R, Huet H, Wang FS, Geslin P, Goudeau A, Selander RK. 1995. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J. Clin. Microbiol. 33:2576-2581.
25. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. 1986. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51:873-884.
26. Zhang GW, Kotiw M, Daggard G. 2002. A RAPD-PCR genotyping assay which correlates with serotypes of group B streptococci. Lett. Appl. Microbiol. 35:247-250. http://dx.doi.org/10.1046/j.1472-765X.2002.01177.x.
27. Manning SD, Lacher DW, Davies HD, Foxman B, Whittam TS. 2005.DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J. Clin. Microbiol. 43:6113-6116. http://dx.doi.org/10.1128/JCM.43.12.6113-6116.2005.
28. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Glaser P, Rusniok C, Crook DW, Harding RM, Bisharat N, Spratt BG. 2003. Multilocus sequence typing system for group B streptococcus. J. Clin. Microbiol. 41:2530-2536. http://dx.doi.org/10.1128/JCM.41.6.2530-2536.2003.
29. Monecke S, Slickers P, Ehricht R. 2008. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol. Med. Microbiol. 53:237-251. http://dx.doi.org/10.1111/j.1574-695X.2008.00426.x.
30. Sorensen UBS, Poulsen K, Ghezzo C, Margarit I, Kilian M. 2010. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. mBio 1(3):e00178-10. http://dx.doi.org/10.1128/mBio.00178-10.
31. Heden LO, Frithz E, Lindahl G. 1991. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur. J. Immunol. 21:1481- 1490. http://dx.doi.org/10.1002/eji.1830210623.
32. Kong F, Gidding HF, Berner R, Gilbert GL. 2006. Streptococcus agalactiae Cβ protein gene (bac) sequence types, based on the repeated region of the cell-wall-spanning domain: relationship to virulence and a proposed standardized nomenclature. J. Med. Microbiol. 55:829-837. http://dx.doi.org/10.1099/jmm.0.46307-0.
33. Creti R, Fabretti F, Orefici G, von Hunolstein C. 2004. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J. Clin. Microbiol. 42:1326-1329. http://dx.doi.org/10.1128/JCM.42.3.1326-1329.2004.
34. Lauer P, Rinaudo CD, Soriani M, Margarit I, Maione D, Rosini R, Taddei AR, Mora M, Rappuoli R, Grandi G, Telford JL. 2005. Genome analysis reveals pili in group B streptococcus. Science 309:105. http://dx.doi.org/10.1126/science.1111563.
35. Dramsi S, Caliot E, Bonne I, Guadagnini S, Prévost MC, Kojadinovic M, Lalioui L, Poyart C, Trieu-Cuot P. 2006. Assembly and role of pili in group B streptococci. Mol. Microbiol. 60:1401-1413. http://dx.doi.org/10.1111/j.1365-2958.2006.05190.x.
36. Rosini R, Rinaudo CD, Soriani M, Lauer P, Mora M, Maione D, Taddei A, Santi I, Ghezzo C, Brettoni C, Buccato S, Margarit I, Grandi G, Telford JL. 2006. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol. Microbiol. 61: 126-141. http://dx.doi.org/10.1111/j.1365-2958.2006.05225.x.
37. Gutekunst H, Eikmanns BJ, Reinscheid DJ. 2004. The novel fibrinogenbinding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells. Infect. Immun. 72:3495-3504. http://dx.doi.org/10.1128/IAI.72.6.3495-3504.2004.
38. Schubert A, Zakikhany K, Pietrocola G, Meinke A, Speziale P, Eikmanns BJ, Reinscheid DJ. 2004. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect. Immun. 72: 6197-6205. http://dx.doi.org/10.1128/IAI.72.11.6197-6205.2004.
39. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. 2009. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J. Infect. Dis. 199:1479-1487. http://dx.doi.org/10.1086/598217.
40. Yang Y, Liu Y, Ding Y, Yi L, Ma Z, Fan H, Lu C. 2013. Molecular characterization of Streptococcus agalactiae isolated from bovine mastitis in eastern China. PLoS One 8:e67755. http://dx.doi.org/10.1371/journal.pone.0067755.
41. Dabul ANG, Camargo ILBC. 2014. Clonal complexes of Staphylococcus aureus: all mixed and together. FEMS Microbiol. Lett. 351:7-8. http://dx.doi.org/10.1111/1574-6968.12358.
42. Robinson DA, Enright MC. 2004. Evolution of Staphylococcus aureus by large chromosomal replacements. J. Bacteriol. 186:1060-1064. http://dx.doi.org/10.1128/JB.186.4.1060-1064.2004.
43. Nimmo G, Steen J, Monecke S, Ehricht R, Slickers P, Thomas JC, Grimmond SM, Robinson DA, Coombs GW. 2014. ST2249-MRSA-III: a second major Staphylococcus aureus recombinant causing healthcare infections in the 1970s. Eur. Cong. Clin. Microbiol. Infect. Dis. (ECCMID), 10 to 13 May 2014, Barcelona, Spain.
44. Brochet M, Rusniok C, Couvé E, Dramsi S, Poyart C, Trieu-Cuot P, Kunst F, Glaser P. 2008. Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc. Natl. Acad. Sci. U. S. A. 105:15961-15966. http://dx.doi.org/10.1073 /pnas.0803654105.
45. Davies HD, Jones N, Whittam TS, Elsayed S, Bisharat N, Baker CJ. 2004. Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J. Infect. Dis. 189:1097-1102. http://dx.doi.org/10.1086/382087.
46. Brzychczy-Wloch M, Gosiewski T, Pawlik D, Szumala-Kakol A, Samead A, Heczko PB. 2012. Occurrence of the hypervirulent ST-17 clone of Streptococcus agalactiae in pregnant women and newborns. Przegl. Epidemiol. 66:395-401. (In Polish.)
47. Ryu H, Park YJ, Kim YK, Chang J, Yu JK. 2014. Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital. J. Infect. Chemother. 20:509-511. http://dx.doi.org/10.1016/j.jiac.2014.03.005.
48. Usein CR, Militaru M, Cristea V, Strəut M. 2014. Genetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area. Mem. Inst. Oswaldo Cruz 109:189- 196. http://dx.doi.org/10.1590/0074-0276140431.
49. Straková L, Musílek M, Motlová J. 2010. Multilocus sequence types in Czech neonatal GBS strains from 2004 to 2008. Epidemiol. Mikrobiol. Imunol. 59:45-47.
50. Tien N, Ho CM, Lin HJ, Shih MC, Ho MW, Lin HC, Lin HS, Chang CC, Lu JJ. 2011. Multilocus sequence typing of invasive group B streptococcus in central area of Taiwan. J. Microbiol. Immunol. Infect. 44:430- 434. http://dx.doi.org/10.1016/j.jmii.2011.04.013.
51. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. 2013. Considerations for a phase-III trial to evaluate a group B streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine 31(Suppl 4):D52-D57. http://dx.doi.org/10.1016/j.vaccine.2013.02.029.
52. Brimil N, Barthell E, Heindrichs U, Kuhn M, Lütticken R, Spellerberg B. 2006. Epidemiology of Streptococcus agalactiae colonization in Germany. Int. J. Med. Microbiol. 296:39-44. http://dx.doi.org/10.1016/j.ijmm.2005.11.001.
53. Dutra VG, Alves VM, Olendzki AN, Dias CA, de Bastos AF, Santos GO, de Amorin EL, Sousa MA, Santos R, Ribeiro PC, Fontes CF, Andrey M, Magalhães K, Araujo AA, Paffadore LF, Marconi C, Murta EF, Fernandes PC, Jr, Raddi MS, Marinho PS, Bornia RB, Palmeiro JK, Dalla-Costa LM, Pinto TC, Botelho AC, Teixeira LM, Fracalanzza SE. 2012. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect. Dis. 14:323. http://dx.doi.org/10.1186/1471-2334-14-323.
54. Harrison LH, Elliott JA, Dwyer DM, Libonati JP, Ferrieri P, Billmann L, Schuchat A. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J. Infect. Dis. 177:998-1002.
55. Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Lütticken R. 2002. rgf encodes a novel two-component signal transduction system of Streptococcus agalactiae. Infect. Immun. 70:2434-2440. http://dx.doi.org/10.1128/IAI.70.5.2434-2440.2002.